Zoledronic acid results in better health-related quality of life following hip fracture: the HORIZON-Recurrent Fracture Trial. (Q48706500)

14 February 2018

title

Zoledronic acid results in better health-related quality of life following hip fracture: the HORIZON-Recurrent Fracture Trial. (English)

1 reference

14 February 2018

1 reference

1 reference

J D Adachi

1

1 reference

14 February 2018

K W Lyles

2

1 reference

14 February 2018

C S Colón-Emeric

3

1 reference

14 February 2018

S Boonen

4

1 reference

14 February 2018

C F Pieper

5

1 reference

14 February 2018

C Mautalen

6

1 reference

14 February 2018

L Hyldstrup

7

1 reference

14 February 2018

C Recknor

8

1 reference

14 February 2018

L Nordsletten

9

1 reference

14 February 2018

K A Moore

10

1 reference

14 February 2018

C Bucci-Rechtweg

11

1 reference

14 February 2018

G Su

12

1 reference

14 February 2018

E F Eriksen

13

1 reference

14 February 2018

J S Magaziner

14

1 reference

14 February 2018

language of work or name

English

0 references

publication date

20 January 2011

1 reference

14 February 2018

Osteoporosis International

published in

1 reference

14 February 2018

volume

22

1 reference

14 February 2018

issue

9

1 reference

14 February 2018

page(s)

2539-2549

1 reference

14 February 2018

https://scigraph.springernature.com/pub.10.1007/s00198-010-1514-9

exact match

0 references

cites work

The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1514-9

Impact of incident vertebral fractures on health related quality of life (HRQOL) in postmenopausal women with prevalent vertebral fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1514-9

Validation of the IOF quality of life questionnaire for patients with wrist fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1514-9

Impact of hip and vertebral fractures on quality-adjusted life years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1514-9

Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1514-9

Epidemiology and outcomes of osteoporotic fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1514-9

Consequences of hip fracture on activities of daily life and residential needs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1514-9

Recovery from hip fracture in eight areas of function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1514-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1514-9

Determinants of health-related quality of life in women with vertebral fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1514-9

The relationship of health-related quality of life to prevalent and incident vertebral fractures in postmenopausal women with osteoporosis: results from the Multiple Outcomes of Raloxifene Evaluation Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1514-9

EuroQol--a new facility for the measurement of health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1514-9

EuroQol: the current state of play

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1514-9

Using the SF-36 and Euroqol on an elderly population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1514-9

Zoledronic acid and clinical fractures and mortality after hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1514-9

The HORIZON Recurrent Fracture Trial: design of a clinical trial in the prevention of subsequent fractures after low trauma hip fracture repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1514-9

Severe hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1514-9

Measuring health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1514-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1514-9

Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1514-9

Development and validation of a specific quality of life module in post-menopausal women with osteoporosis: the QUALIOST.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1514-9

Functional outcome and quality of life following hip fracture in elderly women: a prospective controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1514-9

The association between osteoporotic fractures and health-related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis Study (CaMos)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1514-9

Relationship of health related quality of life to prevalent and new or worsening back pain in postmenopausal women with osteoporosis

21 January 2018

1 reference

12 December 2020

Association of low general health status, measured prospectively by Euroqol EQ5D, with osteoporosis, independent of a history of prior fracture

1 reference

12 December 2020

Modeling valuations for EuroQol health states

1 reference

12 December 2020

Quality of life measurement in osteoporosis

1 reference

12 December 2020

The economic cost of hip fractures among elderly women. A one-year, prospective, observational cohort study with matched-pair analysis. Belgian Hip Fracture Study Group

1 reference

12 December 2020

10.1007/S00198-010-1514-9

Identifiers

DOI

1 reference

14 February 2018

release_jstsgt5tdrdifnyt7vasld6esm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jstsgt5tdrdifnyt7vasld6esm

24 November 2022

mapped directly with Wikidata item

1 reference

14 February 2018